A new study published in JAMA has found that hormone therapy for menopause is safe and the benefits outweigh the risks. The study, which was based on data from the Women’s Health Initiative, concluded that hormone therapy has a low risk of adverse events for women under the age of 60.
Many women had stopped hormone therapy after initial findings showed an increased risk of breast cancer and stroke. However, experts are now urging women to reconsider this decision. Different types of hormones at lower doses are now shown to be safer and more beneficial.
The Women’s Health Initiative study was criticized for using a problematic type of progestin that increased the risk of breast cancer. Hormone therapy is considered safest and most beneficial for women between the ages of 50 and 60.
Risks such as pulmonary embolism can be reduced by using estrogen through skin patches, creams or gels. It is important to note that there is no one-size-fits-all approach to hormone therapy. Women should discuss their options with their healthcare providers to find the best fit for their individual needs.
In addition to helping with menopause symptoms, hormone therapy may also offer protection against bone loss and heart disease. This new research provides important insights for women considering hormone therapy for menopause.
“Travel aficionado. Incurable bacon specialist. Tv evangelist. Wannabe internet enthusiast. Typical creator.”